Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - FREE CASH FLOW
Free Cash Flow SMMT - Summit Therapeutics Inc.
-76.9 M
LAST VALUE
-2.70%
2 YEAR CAGR
-16.84%
5 YEAR CAGR
-22.93%
10 YEAR CAGR